"The ongoing gutting of the FDA is likely to cause American deaths," said the CEO of one medical device developer.

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Zimmer Biomet (NYSE: ZBH) + Zimmer Biomet Holdings, Inc. $112.503 0.58% Open 111.5 Day High 113.6 52 Week High 133.6 52 Week ...

Rhythm Technologies (Nasdaq: IRTC) announced results from two large, real-world analyses demonstrating the benefits of its ...

Teleflex (NYSE: TFX) announced today that it received FDA 510(k) clearance for its AC Range intra-aortic balloon pump (IABP).

The Financial Times reports today that BD (NYSE: BDX) began discussions with competitors for the sale of its Life Sciences ...

Results from the EARLY TAVR trial — the first randomized, controlled FDA pivotal study designed to determine the best ...

Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...

Wandercraft announced today that it enrolled the first participants in a clinical trial evaluating its Personal Exoskeleton ...

JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.

MiRus announced that it launched a U.S. multi-center early feasibility study for its Siegel transcatheter heart valve (THV).

Boston Scientific received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA's 510(k) ...